Rapid Micro Biosystems Reaffirms Its 2024 Total Revenue Guidance Of At Least $27M Compared To Consensus Of $27.066M And The Placement Of At Least 20 Systems; The Company Continues To Expect Gross Margin To Be Positive For Third And Fourth Quarters Of 2024
Portfolio Pulse from Benzinga Newsdesk
Rapid Micro Biosystems reaffirms its 2024 total revenue guidance of at least $27M, which is close to the consensus of $27.066M. The company also expects to place at least 20 systems and anticipates positive gross margins for the third and fourth quarters of 2024.
August 02, 2024 | 11:10 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rapid Micro Biosystems reaffirms its 2024 revenue guidance of at least $27M, close to the consensus of $27.066M. The company also expects to place at least 20 systems and anticipates positive gross margins for the third and fourth quarters of 2024.
The reaffirmation of revenue guidance close to consensus and the expectation of positive gross margins for the latter half of 2024 are positive indicators for RPID. This suggests stability and potential growth, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100